View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Bone/Mineral Metabolism News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 18, 2024
2 min read
Save

FDA clears wearable vibration belt for postmenopausal women with osteopenia

FDA clears wearable vibration belt for postmenopausal women with osteopenia

The FDA cleared a wearable vibration belt device as a non-pharmacologic treatment for postmenopausal women with osteopenia, according to an industry press release.

SPONSORED CONTENT
December 22, 2023
3 min read
Save

Vitamin D supplement does not lower fracture risk among children with 25-(OH)D deficiency

Vitamin D supplement does not lower fracture risk among children with 25-(OH)D deficiency

A once-weekly oral vitamin D supplementation did not reduce fracture risk over a 3-year follow-up among a group of children with vitamin D deficiency in Mongolia, according to findings published in The Lancet Diabetes & Endocrinology.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
December 06, 2023
3 min read
Save

Polygenic risk score incorporating rare variants does not improve fracture prediction

Polygenic risk score incorporating rare variants does not improve fracture prediction

The identification of rare genetic variants that influence bone mineral density did not significantly improve fracture risk screening among a large group of adults, according to data published in Journal of Bone and Mineral Research.

SPONSORED CONTENT
December 04, 2023
2 min read
Save

Long-term hormone therapy after hysterectomy yields benefits up to 20 years

Long-term hormone therapy after hysterectomy yields benefits up to 20 years

Hormone therapy with transdermal estradiol may benefit bone and CV health and overall quality of life up to 20 years after hysterectomy, according to study results published in Menopause.

SPONSORED CONTENT
November 17, 2023
1 min read
Save

Teva gains FDA approval for generic form of Forteo for certain patients with osteoporosis

Teva gains FDA approval for generic form of Forteo for certain patients with osteoporosis

Teva Pharmaceuticals announced FDA approval of a generic version of Forteo in the U.S. for certain women and men with osteoporosis, according to a company press release.

SPONSORED CONTENT
November 16, 2023
2 min read
Save

Bone density rebounds for transgender people during gender-confirming hormone therapy

Bone density rebounds for transgender people during gender-confirming hormone therapy

Transgender people who use gender-confirming hormone therapy long term have increases in bone mineral density back to levels observed before pubertal suppression, according to findings published in JAMA Pediatrics.

SPONSORED CONTENT
November 14, 2023
2 min read
Save

Review: Menopause apps need osteoporosis content, expert insight and simplicity

Review: Menopause apps need osteoporosis content, expert insight and simplicity

Current menopause smartphone apps require more information on osteoporosis, expert input and better quality, functionality and simplicity of use and understanding for the general public, researchers reported.

SPONSORED CONTENT
November 13, 2023
1 min read
Save

Bone density decreases when stopping, never using menopausal hormone therapy

Bone density decreases when stopping, never using menopausal hormone therapy

Postmenopausal women who stopped or never used hormone therapy over a 5-year period experienced a loss in bone density, whereas bone density was maintained for those who continued treatment, researchers reported in Menopause.

SPONSORED CONTENT
November 10, 2023
2 min read
Save

Fracture rates similar between adults with Graves’ disease and general population

Fracture rates similar between adults with Graves’ disease and general population

Adults with Graves’ disease do not have an increased risk for an osteoporosis-related fracture later in life compared with those without Graves’ disease, according to data from a retrospective study published in Thyroid.

SPONSORED CONTENT
October 23, 2023
2 min read
Save

FDA expands indication for vosoritide to include children of all ages with achondroplasia

FDA expands indication for vosoritide to include children of all ages with achondroplasia

The FDA has expanded its accelerated approval of an injectable therapy for treating achondroplasia to include children of all ages, according to a press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails